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What causes slow wound healing rates in diabetes is poorly understood. Wong et al. (2015) report that
an increase in the deployment of neutrophil extracellular traps associated with hyperglycemia slows down
wound healing.Diabetes mellitus is characterized by
elevated concentrations of circulating
glucose (hyperglycemia) and afflicts an
estimated 387 million people globally. In
type I diabetes (T1D), hyperglycemia is
due to a decline in pancreatic beta cells,
whereas type II diabetes (T2D) is caused
by a loss in sensitivity to the glucose-
modulating hormone insulin and beta
cell exhaustion. Recent advances in our
understanding of the mechanisms driving
pathology and successes in reversing
diabetes in mouse models drove the
development of clinical trials aiming to
restore beta cell numbers in early-stage
and advanced patients. Promising phase
II results led to disappointing phase III
trials. On the other hand, T2D can be
easier to manage through diet and exer-
cise. While the etiologies behind diabetic
disease remain elusive and cures that
focus on beta cell restoration appear
distant, understanding and treating the
pathological consequences of hypergly-
cemia is equally important.
One complication of diabetes is slower
wound healing attributed to poor circu-
lation due to the narrowing of the blood
vessels, neuropathy that leads to loss
of pain sensation, and an inefficient im-
mune response that is unable to control
wound infections. However, recent work
by Wong et al. proposes an alternative
explanation that counters the concept
that slower wound healing is due to ineffi-
cient antimicrobial defense (Wong et al.,
2015). In fact, the new data suggest that
the opposite is happening.
The authors examined the function of
immune cells called neutrophils in dia-
betes. Neutrophils are major antimicrobial
effector cells of the innate immune system
and are essential for controlling and elim-
inating microbial infections. They kill mi-
crobes by phagocytosis, degranulation,
and the release of large web-like struc-tures called neutrophil extracellular traps
(NETs). NETs are composed of decon-
densed chromatin in complex with antimi-
crobial factors and are thought to control
a variety of microbes and in particular
fungal pathogens (Branzk et al., 2014).
While, aberrant NETosis is now under-
stood to promote disease (Kaplan and
Radic, 2012), the role of NETs in diabetes
had not been explored.
Several factors suggested that NETs
might be implicated in diabetes including
chronic inflammation and strong evidence
that hyperglycemia increasesNADPHpro-
duction leading to upregulation of reactive
oxygen species (ROS). ROS produced by
the neutrophil NADPH oxidase are impor-
tant signaling mediators during NET for-
mation (NETosis). ROS activate the trans-
location of neutrophil elastase (NE) to the
nucleus and the activation of protein-argi-
nine deiminase 4 (PAD4), an enzyme that
citrulinates histones. Both processes are
thought to be required for NETosis.
The authors first isolated neutrophils
from the blood of T1D and T2D patients
and tested their response to strong
pharmacological NET inducers: the cal-
cium ionophore ionomycin and phorbol
myristate acetate (PMA), which stimu-
latesROSproduction. In vitro, nearly twice
asmany neutrophils derived from patients
releasedNETs in comparison to cells from
healthy donors. Diabetic cells appeared
preactivated, with considerable numbers
of neutrophils releasing NETs even in
the absence of stimulation. Consistent
with this ‘‘poised’’ state, PAD4 was much
more highly expressed in diabetic neutro-
phils. Evidently neutrophils from healthy
donors released more NETs when the
glucose concentration was raised. How-
ever, it remains unclear whether PAD4 up-
regulation is driven by elevated glucose
concentrations. Non-metabolizable sugar
did not affect NETosis, suggesting thatImmunity 43the increase in NETosis might be driven
by elevated ROS through an increase in
glycolysis. This remains to be addressed
along with the mechanisms that upre-
gulate PAD4 protein expression. These
observations were confirmed with neutro-
phils isolated from mice where diabetes
was either induced by chemical (strepto-
zotocin, STZ) or genetic ablation of beta
cells. PMA and ionomycin are strong in-
ducers of NETosis in human neutrophils
yielding 50%–60% NETing cells. The low
level of activation in control neutrophils
reported in Wong et al. is surprising and
suggests that the assays might need
to be optimized to expose the reported
effects of glucose. Alternatively, the au-
thors might have opted for a more strin-
gent quantitation approach compared to
earlier publications, scoring NETs based
on string-like morphology as in Etulain
et al. and excluding decondensed cit-
rulinated H3-positive nuclei lacking this
morphological characteristic (Etulain
et al., 2015). It would therefore be inter-
esting to analyze these data bymeasuring
chromatin decondensation as well.
Subsequently, the authors focused on
wound healing. Histological analysis
showed that NETs formed in the outer
layer of wounds, called the ‘‘scab’’ and
the immediately adjacent wound bed in
healthy non-diabetic mice. Citrulinated
histone H3 was not detected in animals
defective in neutrophil extravasation or
upon neutrophils depletion. Smaller mo-
lecular weight species of histone H3 ap-
peared in these wounds and might be
indicative of proteolytic histone process-
ing during NETosis.
Next theauthorsexploredwhetherNETs
play a role in wound healing by comparing
WT and PAD4-deficient mice. DNA de-
tected by hematoxylin stainingwas scarce
in the scabsof PAD4-deficientmice andas
expected citrulinated histone H3 staining, August 18, 2015 ª2015 Elsevier Inc. 223
Figure 1. Increased NETosis Suppresses Wound Healing in Diabetes
High circulating glucose concentrations are associated with upregulation of PAD4 and an increase in NET
release in response to unknown signals in the skin. NETs are proposed to form in higher numbers in the
wounds of patients with diabetes and result in slower wound reepithelialization and healing.
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Previewswas completely absent. However, another
NET marker would have been helpful to
confirm that uncitrulinated NETs are not
present in these wounds. What triggers
NETosis in wounds remains unclear.
Open skin is not aseptic and microbes
residing in the skin could invade, although
common antibiotics did not affect the
outcome in these experiments. Neutro-
phils have been previously shown to
swarm and release NETs around laser-
induced aseptic wounds (La¨mmermann
et al., 2013). In addition, endogenous
danger molecules were recently shown to
induce NETosis (Warnatsch et al., 2015).
These observations suggest that NETs
could form in response to endogenous
danger molecules released by damaged
skin cells in the absence of infection.
When the authors examined wound
healing, non-diabetic PAD4-deficient
mice displayed a small but consistent in-
crease in wound healing rate. However,
the effect of PAD4 deficiency was
impressive in diabetic animals. Similar
to human patients, hyperglycemic WT
mice exhibit slower wound healing rates.
By comparison, hyperglycemic PAD4-
deficient mice exhibited 30%–40% faster
wound healing than WT controls, indi-
cating a potential connection with the in-
crease in NETosis in response to hyper-
glycemia. Indeed, wounds from diabetic
mice contained higher amounts of citruli-
nated histone H3 protein, but an increase
in NETs analyzed by microscopy has yet224 Immunity 43, August 18, 2015 ª2015 Elsto be demonstrated. Still, the involve-
ment of NETs was corroborated by
showing that DNase I treatment en-
hances wound healing in WT diabetic
mice, but has little effect on diabetic
PAD4-deficient mice. DNase could also
clear necrotic skin cell DNA, but if this
function were more important than NET
clearance, DNase would also affect
PAD4-deficient mice. Therefore, the au-
thors propose that high blood glucose
upregulates PAD4 and consequently
NET release in response to skin trauma,
which slows down the wound healing
process (Figure 1).
These findings raise a number of
interesting questions regarding the role
NETs play in wound healing. Do NETs
form in wounds as a precaution against
infection? What if one were to infect
the wounds of NET-deficient mice?
Furthermore, what is the mechanism of
NET-mediated pathology? NETs might
directly damage keratinocytes as they
can be toxic to cells in culture and cause
damage in vivo (Branzk et al., 2014; Saf-
farzadeh et al., 2012). Alternatively, the
balance of interactions of NETs with mac-
rophages may also play a role since NETs
activate pro-inflammatory cytokine pro-
duction in macrophages (Warnatsch
et al., 2015). NETs might sustain inflam-
mation and block the tissue repair signals
generated when macrophages digest
apoptotic neutrophils (Mantovani et al.,
2011).evier Inc.How glucose regulates NETosis needs
to be addressed and validated for the yet
to be identified triggers of NETosis in
damaged skin. Given that high glucose
is detrimental to many cells, it might
also enhance the release of NET-
inducing molecules in the skin and other
tissues. One can rule out that NET in-
ducers are lower in PAD4-deficient mice
since the enzyme lies downstream in
the pathway, unless a positive feedback
mechanism is in effect.
NE promotes insulin resistance in WT
mice eating a high fat diet (HFD) via the
degradation of insulin receptor sub-
strate-1 (IRS-1) and a decrease in insulin
signaling in hepatocytes and adipocytes
(Talukdar et al., 2012). The implication of
NE in NETosis suggests that NETs might
play a role in T2D pathogenesis. Because
the STZ treatment mimicks T1D by target-
ing beta cells, it would be important to
explore a potential etiological role for
NETs in T2D using a long-term high fat
diet model.
This new research highlights the inter-
play between metabolism and the im-
mune system showing that glucose
affects neutrophil function with medical
significance. It also uncovers a previously
unknown role for NETs in wound healing
and stresses that a misregulated immune
response in diabetes causes complica-
tions in tissues that are not involved in
glucose homeostasis. Importantly, pa-
tients might be able to benefit from an
array of compounds designed to specif-
ically inhibit PAD4. Interestingly, the first
generation PAD inhibitor, Clamidine,
does not effectively block NETosis in
human neutrophils (Warnatsch et al.,
2015), but new specific PAD4 inhibitors
have been developed to inhibit both NET
formation and histone citrulination (Lewis
et al., 2015).REFERENCES
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